Case File
efta-efta01179040DOJ Data Set 9OtherUPCOMING
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01179040
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
UPCOMING
EVENTS
WIS, Well-Being in the
Information Society, 2012
August 22,24, Turku, Finland
Swedish-American Life
Science Summit 2012
August 22-24. Stockholm, Sweden
www_salss.ccnn
RioPartnering Latin America
September 11.13. Rio de Janein,
Brazil
www.techvision.com/bpl
Medtecb Investment Day Nordic
September 13, Stockholm, Sweden
www.medwchinvestmentday.com
BioPharm America 2012
September 19.21, Boston, MA, USA
wrovebdgroup,sem/bpa
BiePartnering Europe
October 7-9, Brussels, Belgium
wwwtechvision.com/bpfe
CPU Worldwide 2012
October 9.11, Madrid, Spain
www.cphi,com
European NledTech Thrum
October 10-12, Brussels. Belgium
www.medtechfor MOM
BIG-Europe 2012
November 12-14, Hamburg,
Germany
wwwebdgroup.com/bioeurope
UPCOMING EVENTS
What will the theme be for this
year's conference?
"The 2012 Summit will focus on the
globalization of the healthcare market,
with an emphasis on Asia, diabetes
and digital health. Our original mis-
sion was to help enable transactions
between America, the largest market
in the world, and Sweden, one of the
most innovative life science countries.
However, over the last few years the sum-
mit has seen an increased participation
from many other countries including
China, Japan, India, Singapore, Korea,
Brazil and Israel. China is arguably the
most attractive emerging pharmaceuti-
cal market, growing by more than 20
percent a year. But we need to under-
stand the market better to fully capture
its potential. Diabetes is a global public
health crisis. One in ten adults will have
diabetes by 2030, posing a huge chal-
lenge to healthcare systems worldwide.
So this is a public health crisis that we
need to shed more light on," Sana Alaj-
movic explains.
Sana Alajmovic goes on to say, "When
thinking about globalization of health-
care, it is only fitting to consider how
wireless technologies are being utilized
in different parts of the world as well as
how these products may improve health
worldwide. The u.s. is ahead of Sweden
at incorporating technology to provide
and facilitate healthcare, but it's just a
matter of time before we will be seeing
more of this in Sweden. Mobile appli-
cations in particular are a fast growing
trend in the u.s."
This is the eighth time that the
summit has been arranged. What
impact do you think that SALSS
has on the life science industry?
"The Swedish life science industry
is currently undergoing a structural
transformation with big pharma out-
sourcing R&D to smaller research com-
panies, institutions and universities.
The shutting down of the AstraZeneca
R&D site in Sodertalje is an example of
that. By creating this global platform
we hope to highlight the latest trends
within business, build a forum for debate
and establish new contacts and new
business opportunities. By introducing
u.s. investors, and at the same time
promoting Swedish life science, we
hope to create investment possibilities.
Hopefully, we can also contribute to col-
laborations being initiated and provide
some inspiration," states Sana Alajmovic.
What is the view on Sweden as a
life science nation in the US?
"Very positive. In the u.s, both Sweden
as a country and the Swedish life science-
industry have excellent reputations.
Swedes are known to be easy to work
with, innovative, flexible and skilled
workers. In relation to its Doe, Sweden
is one of the world's largest spenders on
R&D. Historically the country has had a
strong position and we see not only u.s.
investors but also investors from Asia be-
coming interested in Sweden. However,
there is room for improvement when it
comes to commercializing our research,
compared to the u.s," Sana Alajmovic
concludes. ■
What is the difference between
you and your competitor?
We help you secure your advantage. Contact us on +46 8 5988 7200
or read more on www.albihnszacco.se
aLBIHNs.zacco
58
NORDIC LIFE SCIENCE REVIEW
EFTA01179040
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
www.medwchinvestmentday.comDomain
www.techvision.comDomain
wwwebdgroup.comDomain
wwwtechvision.comPhone
+46 8 5988 7200Related Documents (6)
DOJ Data Set 9OtherUnknown
From: Jeffrey Epstein <jeevacationggmail.com>
3p
DOJ Data Set 10OtherUnknown
EFTA01764793
1p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01989432
0p
DOJ Data Set 10OtherUnknown
EFTA01978832
2p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01890618
0p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01933108
0p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.